Over the past 12 months, 0 insiders at Astria Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on ATXS: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 1, 24 | Christopher MorabitoChief Medical Officer | SELL | 10.0K | $13.59 | $136K |
| Feb 1, 24 | Perceptive Xontogeny Venture Fund, LpDirector | BUY | 2.48M | $12.09 | $30.0M |
| Jan 29, 24 | Christopher MorabitoChief Medical Officer | SELL | 9.2K | $11.15 | $103K |
| Jan 26, 24 | Christopher MorabitoChief Medical Officer | SELL | 800 | $11.02 | $9K |
| Dec 21, 23 | Perceptive Advisors LlcDirector | BUY | 740.0K | $6.20 | $4.6M |
| Oct 16, 23 | Perceptive Life Sciences Master Fund LtdDirector | BUY | 614.1K | $6.51 | $4.0M |
| Dec 19, 22 | Perceptive Life Sciences Master Fund LtdDirector | BUY | 908.3K | $11.01 | $10.0M |
| Nov 19, 21 | Andrew KomjathyChief Commercial Officer | BUY | 100 | $6.70 | $670 |
Over the past 12 months, insiders at Astria Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ATXS, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ATXS insider purchase in our data was $30.0M by Perceptive Xontogeny Venture Fund, Lp, Director, filed on Feb 1, 24.
0 different insiders at Astria Therapeutics, Inc. filed open-market SEC Form 4 transactions on ATXS over the last 12 months.
InsiderTape plots every ATXS insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Astria Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →